Movement Alert｜Alibaba Health Falls 3.28% in Regular Trading, UBS Cuts Target Price Amid Sector-Wide Selling

Market Focus07-07

On July 7, Alibaba Health fell 3.28% in regular trading, trading at HK$3.25 per share, with turnover of HK$193 million.

On the news front, UBS maintained its Sell rating on Alibaba Health and further cut its target price from HK$3.6 to HK$3.1, while lowering earnings forecasts for fiscal years 2027 to 2029 by 5%. UBS projects revenue and adjusted net profit compound annual growth rates of 12% and 5% respectively for fiscal years 2026 to 2029, citing slowing revenue growth and margin pressure from increased investment in AI and supply chain.

Meanwhile, the healthcare e-commerce sector came under broad selling pressure, with peer JD Health declining 4.71% and PA Good Doctor falling 5.0%, creating additional drag on Alibaba Health. The company had reported solid fiscal year 2026 results on July 6, with revenue of RMB 34.255 billion (up 12%) and net profit of RMB 1.936 billion (up 35.2%), but these were offset by the negative brokerage sentiment and sector weakness.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1194022429?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-07 14:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194022429","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Alibaba Health Falls 3.28% in Regular Trading, UBS Cuts Target Price Amid Sector-Wide Selling","media":"Market Focus","content":"<p><p>On July 7, Alibaba Health fell 3.28% in regular trading, trading at HK$3.25 per share, with turnover of HK$193 million.</p><p>On the news front, UBS maintained its Sell rating on Alibaba Health and further cut its target price from HK$3.6 to HK$3.1, while lowering earnings forecasts for fiscal years 2027 to 2029 by 5%. UBS projects revenue and adjusted net profit compound annual growth rates of 12% and 5% respectively for fiscal years 2026 to 2029, citing slowing revenue growth and margin pressure from increased investment in AI and supply chain.</p><p>Meanwhile, the healthcare e-commerce sector came under broad selling pressure, with peer JD Health declining 4.71% and PA Good Doctor falling 5.0%, creating additional drag on Alibaba Health. The company had reported solid fiscal year 2026 results on July 6, with revenue of RMB 34.255 billion (up 12%) and net profit of RMB 1.936 billion (up 35.2%), but these were offset by the negative brokerage sentiment and sector weakness.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Alibaba Health Falls 3.28% in Regular Trading, UBS Cuts Target Price Amid Sector-Wide Selling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Alibaba Health Falls 3.28% in Regular Trading, UBS Cuts Target Price Amid Sector-Wide Selling\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-07 14:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 7, Alibaba Health fell 3.28% in regular trading, trading at HK$3.25 per share, with turnover of HK$193 million.</p><p>On the news front, UBS maintained its Sell rating on Alibaba Health and further cut its target price from HK$3.6 to HK$3.1, while lowering earnings forecasts for fiscal years 2027 to 2029 by 5%. UBS projects revenue and adjusted net profit compound annual growth rates of 12% and 5% respectively for fiscal years 2026 to 2029, citing slowing revenue growth and margin pressure from increased investment in AI and supply chain.</p><p>Meanwhile, the healthcare e-commerce sector came under broad selling pressure, with peer JD Health declining 4.71% and PA Good Doctor falling 5.0%, creating additional drag on Alibaba Health. The company had reported solid fiscal year 2026 results on July 6, with revenue of RMB 34.255 billion (up 12%) and net profit of RMB 1.936 billion (up 35.2%), but these were offset by the negative brokerage sentiment and sector weakness.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00241","symbol_name":"阿里健康","start_time":0,"source_url":"","article_id":"1194022429","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194022429","pubTimestamp":1783404226,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 7, Alibaba Health fell 3.28% in regular trading, trading at HK$3.25 per share, with turnover of HK$193 million.On the news front, UBS maintained its Sell rating on Alibaba Health and further...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00241":"阿里健康"},"translate_title":"动向提示|阿里巴巴-SW健康常规交易跌3.28%全行业抛售下瑞银下调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"On July 7, Alibaba Health fell 3.28% in regular trading, trading at HK$3.25 per share, with turnover of HK$193 million.On the news front, UBS maintained its Sell rating on Alibaba Health and further cut its target price from HK$3.6 to HK$3.1, while lowering earnings forecasts for fiscal years 2027 to 2029 by 5%. UBS projects revenue and adjusted net profit compound annual growth rates of 12% and 5% respectively for fiscal years 2026 to 2029, citing slowing revenue growth and margin pressure from increased investment in AI and supply chain.Meanwhile, the healthcare e-commerce sector came under broad selling pressure, with peer JD Health declining 4.71% and PA Good Doctor falling 5.0%, creating additional drag on Alibaba Health. The company had reported solid fiscal year 2026 results on July 6, with revenue of RMB 34.255 billion (up 12%) and net profit of RMB 1.936 billion (up 35.2%), but these were offset by the negative brokerage sentiment and sector weakness.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1194022429","isCrawlerRequest":true}